TORRENT LAMOTRIGINE DT 200 lamotrigine 200mg dispersible tablet blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

lamotrigine, Quantity: 200 mg

Available from:

Torrent Australasia Pty Ltd

INN (International Name):

Lamotrigine

Pharmaceutical form:

Tablet, dispersible

Composition:

Excipient Ingredients: magnesium stearate; microcrystalline cellulose; mannitol; aspartame; povidone; croscarmellose sodium; colloidal anhydrous silica; crospovidone; Flavour

Administration route:

Oral

Units in package:

56 tablets

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Torrent Lamotrigine dispersible tablets are indicated for the treatment of: Partial and generalised seizures in adults and children. There is extensive experience with Torrent Lamotrigine use initially as add-on therapy. Torrent Lamotrigine has also been found to be effective as monotherapy following withdrawal of concomitant antiepileptic drugs. Initial monotherapy in newly diagnosed paediatric patients is not recommended. (see Actions, Clinical trials.)

Product summary:

Visual Identification: White to off white, round, flat faced beveled edge tablets, plain on both sides.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2008-09-29